Literature DB >> 2228027

Production of bovine immunoregulatory molecules by xenogeneic hybrids.

R A Collins1, B V Jones, G Oldham.   

Abstract

The study of bovine cytokines and lymphocyte surface markers has been restricted by the lack of stable, long-lived, easily maintained cell lines. To address this problem, bovine mononuclear leucocytes were fused with the mouse thymoma cell line BW5147 to produce interspecies hybrid cell lines and clones. Hybridomas were produced which contained more than 40 chromosomes and expressed one or more bovine leucocyte surface markers, they grew well and were cloned without the use of exogenous factors. Fusion rates were improved when exogenous factors, including recombinant human interleukin-2 (rhIL-2), were added. Some hybrids secreted immunoregulatory factors able to maintain the growth of either an IL-2-dependent bovine T-cell line (C625) and/or preactivated normal bovine B cells. Anti-human IL-2 partially blocked the T-cell growth factor (TCGF) activity produced by these hybrids. The release of growth factors by the hybrid clones 5/AA6/16 and 5/AA6/19 was augmented by concanavalin A stimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228027      PMCID: PMC1384314     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Effect of recombinant IL 2 and gamma-IFN on proliferation and differentiation of human B cells.

Authors:  T Nakagawa; T Hirano; N Nakagawa; K Yoshizaki; T Kishimoto
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

2.  T-cell lines producing antigen-specific suppressor factor.

Authors:  S Kontiainen; E Simpson; E Bohrer; P C Beverley; L A Herzenberg; W C Fitzpatrick; P Vogt; A Torano; I F McKenzie; M Feldmann
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

3.  Characterization of a subset of bovine T lymphocytes that express BoT4 by monoclonal antibodies and function: similarity to lymphocytes defined by human T4 and murine L3T4.

Authors:  C L Baldwin; A J Teale; J G Naessens; B M Goddeeris; N D MacHugh; W I Morrison
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

4.  Regulation of antibody response in different immunoglobulin classes. V. Establishment of T hybrid cell line secreting IgE class-specific suppressor factor.

Authors:  T Watanabe; M Kimoto; S Maruyama; T Kishimoto; Y Yamamura
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

5.  Production of interspecies T cell hybrids which retain differentiation specific surface antigens.

Authors:  P G Messer Peters; M E Kamarck; F H Ruddle
Journal:  J Immunol Methods       Date:  1983-08-12       Impact factor: 2.303

6.  Specific bovine monoclonal antibody produced by a re-fused mouse/calf hybridoma.

Authors:  E M Tucker; A R Dain; S W Clarke; R A Donker
Journal:  Hybridoma       Date:  1984

7.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

8.  Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.

Authors:  J J van Dongen; A H Geurts van Kessel; I L Wolvers-Tettero; M A Versnel; A van Oudenaren; E Schoenmaker; A Hagemeijer
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

9.  Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction.

Authors:  G Köhler; I Lefkovits; B Elliott; A Coutinho
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

10.  Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules.

Authors:  M Okada; N Yoshimura; T Kaieda; Y Yamamura; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.